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Mutations of skeletal muscle sodium channel a subunit
(SCN4A) gene are associated with a group of allelic diseases,
including periodic paralysis, paramyotonia congenital, sodium
channel myotonia, and congenital myasthenic syndrome.1
Periodic paralysis is characterized by episodic attacks of ﬂaccid
weakness with the ﬂuctuation of serum potassium, which are
usually limited to skeletal muscles owing to tissue speciﬁc
expression of channel isoforms.2 However, periodic paralysis is
occasionally concomitant with cardiac arrhythmia, essential
tremor, and epilepsy. Here we described a case of normokalemic
periodic paralysis with involuntary movements and generalized
epilepsy associated with two novel heterozygous missense
mutations in SCN4A gene.
2. Case report
The patient gave written informed consent for this case study,
approved by Institute ethical committee. A 19-year-old man
suffered from paroxysmal limb shake since one year old. The
manifestation was prominent in his right hand, and got more
serious when he was nervous. He experienced generalized tonic–
clonic seizure at the age of 10. The electroencephalogram (EEG)
indicated epileptic discharge, but cerebral MRI showed no* Corresponding author at: Department of Neurology, The First Afﬁliated Hospital
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the boy was administrated valproic acid 600 mg daily. The seizures
gradually disappeared in following two years, while the limb shake
still persisted. At the age of 13, he started to have episodic muscle
weakness, occasionally with postcritic myalgia. The attacks were
usually triggered by cold or rest after strenuous exercise. The
frequency of attacks was four times a year and the duration ranged
from several hours to one day, while serum potassium level was
normal. The episodic weakness was irresponsive to oral potassium
administration. Nobody in his family had similar paralytic episodes
or other neural disorders. When he came to our hospital, the
attacks happened once a week, accompanied with postcritic
diarrhea.
Neurological examination revealed muscle strength 4+/5
(MRCS, grades 0–5) grade in the right limbs. Right thigh was
slight atrophy, while right arm was stiffness and hypertrophy. No
muscle cramps could be elicited by palpating muscles. There are no
abnormalities in cognitive function. Serum creatine kinase was
2500 IU/L (normal 24–195 IU/L). The potassium and thyroid
hormones levels were normal. Electrocardiogram showed sinus
arrhythmia. Echocardiography, electroencephalogram and cere-
bral MRI were normal. Electromyogram showed myopathic
changes. A long exercise test indicated that the compound muscle
action potential (CMAP) amplitude was progressively decreased by
62.3% over 50 min after ﬁnishing the exercise and persisted at this
low level for 2 h.
The striking features of muscle biopsy were some vacuoles
located around subsarcolemmal (Fig. 1a and c). Some vacuoles
were ﬁlled with periodic acidic schiff (PAS) positive materials
(Fig. 1b), while other vacuoles were spared (Fig. 1d). Ultrastruc-
tural examinations conﬁrmed numerous glycogen granules
deposited under the subsarcolemmal (Fig. 1e). A few dilated
myotubules were observed (Fig. 1f).
Genomic DNA was extracted from blood samples of the
patient. Coding exons of the SCN4A gene were ampliﬁed using
polymerase chain reaction (PCR) with intronic primers. After
puriﬁcation, PCR products were directly sequenced with an ABI
3730 DNA Analyzer (Applied Biosystems, Inc., CA, USA). Genetics
screening found two novel missense mutations (p.Glu974Asp and
p.Lys1126Ile) in SCN4A gene (Fig. 2a and b). However, no
mutations were found in the acid maltase, myophosphorylase,served.
Fig. 1. HE staining of muscle biopsy revealed some vacuoles located around subsarcolemmal (a, c, indicated by the arrows). Some vacuoles were ﬁlled with periodic acidic
schiff (PAS) positive materials (b, indicated by the arrows), while other vacuoles were not (d). Numerous glycogen granules under the subsarcolemmal (e) and a few dilated
myotubules (f, indicated by the arrow) were observed.
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subunit (SCN1A), a2 subunit (SCN2A) and b1 subunit (SCN1B)
genes (data not shown). The two mutations are absent in 100
healthy Chinese subjects.
3. Discussion
An interesting issue raised by this patient is the relationship
between periodic paralysis and neural disorders. The episodic
weakness was onset from childhood with normakalemia during
the attack and persistent CAMP decrease in the long exercise test.
The clinical pictures are in accordance with normakalemic periodic
paralysis (NormPP), although NormPP is believed as a variant of
hyperkalemic periodic paralysis.3 On the other hand, paroxysmal
limb shake and generalized epilepsy indicated the lesions in
central nervous system. Accordingly, the syndromes of this caseFig. 2. Two novel mutations of the SCN4A gene were identiﬁed in a single patient.
The c.2922G > T substitution in 15 exon of SCN4A gene resulted in p.Glu974Asp (a).
Another c.3377A > T substitution in 18 exon of SCN4A gene resulted in p.Lys1126Ile
(b). The mutations were indicated by the arrows.seemed to be explained by defects in genes associated with
channelopathy. However, the clinical phenotypes in association
with the ion channel genes mutations are usually limited to a
single organ owing to tissue speciﬁc expression of channel
isoforms. For example, mutations in cerebral SCN1A, SCN2A and
SCN1B genes have been associated with four idiopathic epilepsy
syndromes, while mutations of SCN4A are linked to muscular
disorders.4 Although hypokalemic periodic paralysis with multi-
plex epilepsies has been occasionally described, clinical and
genetic ﬁndings demonstrate that epileptic activities were
independent of periodic paralysis. Therefore, the correlation
between NormPP, involuntary movements and generalized epi-
lepsy in this case is still open to discuss.
In this report, we identiﬁed two novel SCN4A mutations and
excluded gene mutations associated with glycogen storage disease
and epilepsy-causing sodium channels. The p.Lys1126Ile mutation is
located in the S4 segment of domain III (DIIIS4) of SCN4A protein,
which is completely conserved in sodium channels of different
species. The positive residues in the S4 segments serve as voltage-
sensors of the voltage dependent sodium channels. Accordingly, the
p.Lys1126Ile mutation is closely related to periodic paralysis.
However, the status of p.Glu974Asp mutation remained elusive,
which might play a synergetic role for p.Lys1126Ile mutation. The
pathogenic mechanism of the novel mutations should be further
elucidated.
In conclusion, a double mutation identiﬁed in one case is a rare
phenomenon for a dominant inherited disease. The ﬁndings
expand the mutation spectrum of SCN4A gene, and our case
indicates that normakalemic periodic paralysis may be associated
with cerebral dysfunctions.
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